跳至主要内容
临床试验/ISRCTN16409847
ISRCTN16409847进行中(未招募)Unknown

Investigation of novel and established therapies in a human intravenous lipopolysaccharide model of sepsis

Belfast Health and Social Care Trust0 个研究点目标入组 65 人开始时间: 2024年4月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy adult volunteers aged between 18 and 40 years of age
  • 2. Informed consent to participate

排除标准

  • 1. Current participation in a clinical trial
  • 2. Pregnant or breastfeeding
  • 3. Current history of smoking
  • 4. Alcohol intake > 21 units per week
  • 5. Intake of any prescription and over-the-counter medication (except paracetamol, hormonal contraceptives and hormonal replacement therapy) within 7 days prior to the first dose of IMP
  • 6. Oxygen saturation <95% breathing room air
  • 7. Abnormal findings on history, examination or laboratory tests suggestive of underlying illness (in the opinion of the clinician undertaking screening)
  • 8. History of recurrent vaso-vagal episodes
  • 9. Known history of allergy to imatinib

研究者

相似试验

Investigating the effects of intravenous fluids and... | 临床试验